Peer Review is the weekly biopharma jobs report from Endpoints News.
→ Musculoskeletal company Flexion Therapeutics $FLXN said co-founder Neil Bodick will transition to CSO from CMO. Yamo Deniz becomes CMO. Deniz was VP and global head of medical for rare diseases at the Genzyme unit of Sanofi.
→ Anti-infective firm Entasis Therapeutics named Mike Gutch CFO and CBO. He was executive director of corporate development at AstraZeneca.
→ Lorianne Masuoka joins Marinus Pharmaceuticals as their new CMO. She’s a neurologist who held chief medical roles at InVivo, Cubist, and Nektar previously.
→ Taylor Crouch is replacing Keith Murphy as CEO of San Diego-based Organovo $ONVO, a developer of human tissue models. Crouch was the CEO of eStudySite, and earlier in his career was senior vice president of marketing and sales at Parexel.
→ Oxford’s e-Therapeutics appointed Raymond Barlow as CEO. Barlow was previously executive director of corporate development at Amgen.
→ Destiny Pharma, an anti-microbial biotech, named Neil Clark as CEO. Bill Love, the previous CEO and scientific founder, is now the CSO.
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 30,000+ biopharma pros who read Endpoints News by email every day.Free Subscription